Timing of Dialysis Initiation: Early vs Late

Key Evidence Against Early Dialysis

• The American Journal of Kidney Diseases recommends that dialysis should NOT be initiated early (GFR >10 mL/min/1.73 m²) in asymptomatic patients, as early initiation provides no survival benefit and may cause harm 1, 2, 3, 4
• When corrected for lead-time bias, there is no clear survival advantage to starting dialysis earlier at higher GFR levels 1, 2, 3, 4
• The observational data consistently show that patients with more comorbidities tend to start dialysis at higher GFR levels, but these frailer patients do not live as long as healthier patients who start later—this reflects patient selection bias rather than benefit from early initiation 1, 2, 3, 4

Recommended Approach to Dialysis Initiation

GFR Thresholds

• Conservative management should continue until GFR decreases to <15 mL/min/1.73 m² unless specific indications exist 2, 3, 5, 6
• Target GFR for initiation is approximately 10 mL/min/1.73 m² based on theoretical considerations 1, 2, 5, 6
• The mean GFR at dialysis initiation in 2003 was 9.8 mL/min/1.73 m², with lower values (7-9 mL/min/1.73 m²) for young and middle-aged adults and higher values (10-10.5 mL/min/1.73 m²) for children and elderly patients 1, 2, 5, 6

Clinical Indications That Override GFR (Initiate Earlier)

• Dialysis should be initiated when any of the following are present, regardless of GFR: protein-energy malnutrition, uremic symptoms, volume overload refractory to diuretic therapy, uncontrolled hypertension, progressive deterioration in nutritional status, metabolic derangements 7, 1, 2
• Protein-energy malnutrition that develops or persists despite vigorous attempts to optimize intake, with no apparent cause other than low nutrient intake 3, 4
• Uremic symptoms: pericarditis, encephalopathy, intractable nausea/vomiting, bleeding diathesis 7, 1, 2
• Volume overload refractory to diuretic therapy 2, 3, 5, 6
• Uncontrolled hypertension despite maximal medical management 2, 3, 5, 6
• Progressive deterioration in nutritional status: declining edema-free body weight, falling serum albumin, lean body mass <63% 7
• Metabolic derangements: severe metabolic acidosis, hyperkalemia unresponsive to medical therapy 2, 3, 5, 6

Conditions Allowing Delayed Initiation (Even with GFR <10)

• Dialysis may be safely deferred even when GFR <10 mL/min/1.73 m² if ALL of the following are present: stable or increased edema-free body weight, adequate nutritional parameters, complete absence of clinical signs or symptoms attributable to uremia 7

Critical Caveats and Pitfalls

Limitations of GFR Estimation

• In patients with unusual creatinine generation or altered tubular secretion, measured GFR using 24-hour urine collection for creatinine and urea clearance is more accurate 2, 3, 5
• A weekly Kt/V of 2.0 approximates a kidney urea clearance of 7 mL/min and creatinine clearance of 9-14 mL/min/1.73 m² 7

Risks of Dialysis Itself

• Dialysis is not innocuous and does not replace all kidney functions 2, 3, 5, 6
• Hemodialysis-related hypotension may accelerate loss of residual kidney function 2, 3, 5, 6
• Vascular access complications 2, 3, 5, 6
• Dialysate-related complications 2, 3, 5, 6
• Significant burden on patient, family, and healthcare system 2, 3, 5, 6

Initial Dialysis Prescription

• When dialysis is initiated, the first treatment must use a "low and slow" approach 8
• Initial session duration: 2-2.5 hours (not full 4 hours) 8
• Reduced blood flow rates: 200-250 mL/min 8
• Minimal ultrafiltration during first session, focusing on clearance rather than fluid removal 8
• Gradual dose escalation over subsequent sessions as tolerated 8

Clinical Decision Framework

• The decision to initiate dialysis represents a compromise designed to maximize quality of life by extending the dialysis-free period while avoiding complications 2, 3, 5, 6
• This requires clinical judgment based on individual patient factors: age, comorbidities, vascular access status, transplant candidacy, home dialysis eligibility 2, 3, 5, 6

Initiating Dialysis in Asymptomatic Patients with Advanced CKD

1. Core Indications for Starting Dialysis (KDOQI)

2. Evidence Against Early (GFR‑Based) Initiation (KDOQI)

3. Conservative Management Criteria (American Society of Nephrology)

4. Monitoring and Assessment Strategies

5. Preparation for Future Dialysis (European Guidelines)

6. Risks Associated with Dialysis Initiation (KDOQI)

All bullet points are derived from peer‑reviewed sources with the citation IDs shown in brackets.

Clinical Indications and Timing for Initiating Dialysis

Indications for Initiation (Symptom‑Driven)

• Initiate dialysis when patients develop uremic complications such as pericarditis, encephalopathy, intractable nausea/vomiting, or bleeding diathesis that are attributable to renal failure【@3】.
• Start dialysis for refractory volume overload that persists despite maximal diuretic therapy (e.g., ongoing pulmonary edema, peripheral edema, dyspnea)【@2】【@4】.
• Begin dialysis in the presence of uncontrolled hypertension that cannot be controlled with optimal medical therapy【@2】【@4】.
• Severe hyperkalemia (generally > 6.5 mmol/L or any level with ECG changes) unresponsive to dietary restriction, diuretics, potassium binders, and insulin/dextrose warrants dialysis【@2】【@4】.
• Severe metabolic acidosis (pH < 7.20 or bicarbonate < 10 mmol/L) that does not improve with oral alkali therapy is an indication for dialysis【@2】【@4】.
• Protein‑energy malnutrition that persists despite aggressive nutritional interventions, without another identifiable cause, should prompt dialysis initiation【@1】【@5】【@4】.

GFR Thresholds and Timing

• Conservative management is appropriate until estimated GFR falls below 15 mL/min/1.73 m², unless any of the above clinical indications arise【@1】【@2】【@4】.
• The theoretical GFR target for initiating dialysis is about 10 mL/min/1.73 m²; in practice, the mean initiation GFR is 9.8 mL/min/1.73 m² (range 7–9 for younger adults, 10–10.5 for children and the elderly)【@1】【@5】【@2】【@4】.

Outcomes of Early Initiation

• Initiating dialysis at a GFR > 10 mL/min/1.73 m² provides no survival benefit and may cause harm; this finding comes from the IDEAL randomized controlled trial (high‑quality evidence)【@3】【@6】.
• After adjusting for lead‑time bias, there is no clear survival advantage to starting dialysis at higher versus lower GFR levels【@1】【@5】【@2】【@4】.

Limitations of eGFR in Advanced CKD

• Serum‑creatinine‑based eGFR is unreliable in advanced CKD because it is heavily influenced by muscle mass, leading to overestimation in sarcopenic patients【@3】【@6】.
• In individuals with atypical creatinine generation or altered tubular secretion, a measured GFR using 24‑hour urine creatinine and urea clearances should be obtained rather than relying on eGFR【@4】【@3】.
• Observational studies that reported higher mortality with higher eGFR at dialysis start are likely confounded by patient selection bias (sicker, frailer patients start earlier)【@1】【@5】【@2】【@4】.

Risks Associated with Dialysis Itself

• Hemodialysis‑related hypotension can accelerate loss of residual kidney function, which is important for quality of life【@2】【@4】.
• Dialysis does not replace all kidney functions and imposes a substantial physical, emotional, and economic burden on patients, families, and health‑care systems【@1】【@2】【@4】.

Safe Deferral of Dialysis in Asymptomatic Patients

• Asymptomatic patients can safely postpone dialysis until an eGFR of 5–7 mL/min/1.73 m² when careful clinical monitoring is maintained; this strategy was demonstrated in the IDEAL trial (randomized evidence)【@6】.

Timing of Dialysis Initiation in End‑Stage Kidney Disease

1. Evidence Against Early, GFR‑Based Initiation

• Initiating dialysis in asymptomatic stage 5 CKD patients when estimated GFR is >10 mL/min/1.73 m² does not improve survival and may cause harm; dialysis should be started only after uremic symptoms or specific clinical complications appear, irrespective of GFR level. Evidence level: high (IDEAL randomized controlled trial). 14

• The IDEAL trial compared “early start” (GFR 10–14) with “late start” (symptom‑driven, actual start ≈ 7–8). It found no difference in all‑cause mortality between groups. Evidence level: high. 14

• The same trial showed no difference in cardiovascular events or infectious complications between early and late start groups. Evidence level: high. 14

• Quality‑of‑life scores were similar for early‑ and late‑start patients in the IDEAL trial. Evidence level: high. 14

• Rates of dialysis‑related complications (e.g., access problems, hypotension) were comparable between early and late initiation. Evidence level: high. 14

• Patients in the late‑start arm experienced a median 5.6‑month longer dialysis‑free interval before requiring therapy. Evidence level: high. 14

• Observational studies, after adjustment for lead‑time bias, consistently demonstrate no survival advantage and possibly worse outcomes with early initiation. Evidence level: moderate. [15][16]14

2. Absolute, Symptom‑Driven Indications for Immediate Dialysis

• Uremic pericarditis (pericardial friction rub or effusion) warrants immediate dialysis regardless of GFR. 16
• Uremic encephalopathy (confusion, asterixis, seizures) is an indication for prompt initiation. 16
• Intractable nausea or vomiting that does not respond to anti‑emetic therapy requires dialysis. 16
• Bleeding diathesis due to uremic platelet dysfunction should trigger dialysis initiation. 16
• Refractory volume overload (persistent pulmonary or peripheral edema) despite maximal diuretic therapy mandates dialysis. 16
• Uncontrolled hypertension that cannot be managed with optimal medical therapy is an indication for dialysis. 16
• Severe hyperkalemia (>6.5 mmol/L or any level with ECG changes) unresponsive to medical measures necessitates dialysis. 16
• Severe metabolic acidosis (pH < 7.20 or bicarbonate < 10 mmol/L) refractory to oral alkali therapy is a trigger for dialysis. 16
• Persistent protein‑energy malnutrition despite aggressive nutritional support, with no other identifiable cause, calls for dialysis. Evidence level: moderate. [15][16]

3. Conservative Management and Safe Deferral

• In the absence of the above absolute indications, conservative management should be continued until measured GFR falls below 15 mL/min/1.73 m². Evidence level: moderate. [15][16]

• Asymptomatic patients can safely defer dialysis until measured GFR reaches 5–7 mL/min/1.73 m², provided close monitoring is in place. Evidence level: high (IDEAL trial). 14

• Monitoring protocol for safe deferral:

  • Measured GFR (24‑hour urine creatinine and urea clearance) every 3 months; reliance on eGFR alone is discouraged because serum‑creatinine estimates are unreliable in advanced CKD. Evidence level: high. 14

4. Risks and Harms Associated with Early Initiation

• Hemodialysis‑related hypotension accelerates loss of residual kidney function, which is essential for volume control, phosphate clearance, and quality of life. Evidence level: moderate. 16

• Vascular access complications (infection, thrombosis) increase morbidity when dialysis is started earlier. Evidence level: moderate. [15][16]

• Dialysis does not replace all native kidney functions and imposes substantial physical, psychological, and economic burdens on patients, families, and health‑care systems. Evidence level: moderate. [15][16]

• Observational data suggesting higher mortality with earlier start are confounded by selection bias: sicker, frailer patients tend to start earlier, and their poorer outcomes reflect underlying illness rather than timing of dialysis. Evidence level: moderate. [15][16]

5. Limitations of eGFR in Advanced CKD

• In individuals with low muscle mass (e.g., elderly, malnourished, sarcopenic), serum‑creatinine‑based eGFR overestimates true GFR, potentially delaying needed dialysis. Evidence level: high. 14

• When clinical symptoms appear discordant with eGFR, measured GFR (24‑hour urine collection) should be used to guide decision‑making. Evidence level: high. 14

Evidence‑Based Indications for Initiating Dialysis in Advanced CKD

Clinical Indications for Immediate Dialysis

• Pericarditis (pericardial friction rub or effusion) constitutes an absolute indication for starting dialysis, regardless of GFR. (expert consensus) 17
• Peripheral neuropathy attributable to uremia is an absolute indication for dialysis initiation, independent of renal function level. (expert consensus) 17
• Refractory volume overload that persists despite maximal diuretic therapy mandates dialysis initiation. (expert consensus) 18
• Uncontrolled hypertension that remains despite optimal medical management is a trigger for immediate dialysis. (expert consensus) 18
• Protein‑energy malnutrition that does not improve with aggressive nutritional interventions, with no other identifiable cause, requires dialysis. (expert consensus) 17

GFR‑Based Guidance (When No Clinical Indications Are Present)

• Conservative (non‑dialysis) management should be continued until estimated GFR falls below 15 mL/min/1.73 m², provided no absolute clinical indications have emerged. (expert consensus) 18

Limitations of eGFR in Advanced CKD

• Serum‑creatinine‑based eGFR is unreliable when true GFR is <15 mL/min/1.73 m² and should not be used as the sole determinant for dialysis initiation. (expert consensus) 18
• When clinical findings are discordant with eGFR, a measured GFR obtained from a 24‑hour urine collection for creatinine and urea clearances should be performed to guide decision‑making. (expert consensus) 18

Role of Conservative Management

• All patients with stage 5 CKD should be offered a discussion of conservative (non‑dialysis) management as a legitimate treatment option, especially those who are older, frail, or have multiple comorbidities. (expert consensus) 18

Immediate Initiation of Dialysis in Advanced CKD When Absolute Indications Are Present

Respiratory Compromise from Volume Overload

• In patients with end‑stage kidney disease, refractory fluid overload that requires supplemental oxygen to keep SpO₂ > 90 % is an absolute indication for urgent dialysis (KDIGO).  [19][20]
• Progressive peripheral edema together with a new oxygen requirement on hospital day 3 signals worsening pulmonary congestion that is unresponsive to diuretics, mandating dialysis (KDIGO). [21][19]

Severe Hyperkalemia

• Serum potassium > 6.0 mmol/L in the setting of stage 5 CKD constitutes severe hyperkalemia that warrants immediate dialysis, regardless of ECG changes (KDIGO). [21][19]

Severe Metabolic Acidosis

• A bicarbonate level around 16 mmol/L in a patient with an estimated GFR ≈ 10 mL/min/1.73 m² reflects severe metabolic acidosis that is unlikely to be corrected with oral alkali alone and therefore requires dialysis (KDIGO). [21][19]

Uremic Symptoms

• The presence of classic uremic manifestations—persistent nausea, pruritus, and anorexia—combined with markedly elevated BUN (≈ 100 mg/dL) is an indication for dialysis initiation (KDIGO). [21][19]20

GFR‑Based Decision‑Making Is Insufficient

• Initiating dialysis solely on the basis of a low GFR (≈ 11 mL/min/1.73 m²) is not recommended; clinical indications must drive the decision (KDIGO). [19][20]
• The IDEAL trial demonstrated no survival benefit for early dialysis (GFR 10‑14 mL/min/1.73 m²) in asymptomatic patients, underscoring that symptomatic patients with absolute indications should not be managed conservatively (KDIGO). [19][20]

Vascular Access Considerations

• An arteriovenous fistula requires 6‑8 weeks of maturation (flow > 600 mL/min, diameter > 0.6 cm, depth 0.5‑1.0 cm) before it can be safely cannulated (“Rule of 6s”) (KDIGO). [22][23]
• Cannulating a fistula within the first month markedly increases the risk of infiltration, hematoma, and permanent loss; a tunneled central venous catheter (preferably internal jugular or femoral) should be used for immediate access (KDIGO). 23

Initial “Low‑and‑Slow” Dialysis Prescription to Prevent Disequilibrium

• For patients with very high BUN, the first hemodialysis session should be limited to 2‑2.5 hours (instead of the usual 4 hours) to reduce the risk of dialysis disequilibrium syndrome (KDIGO). 19
• Blood flow rates should be set at 200‑250 mL/min (lower than the standard 300‑400 mL/min) during the initial treatment (KDIGO). 19
• Minimal ultrafiltration should be performed on the first session; the focus should be on solute clearance while closely monitoring vital signs every 15‑30 minutes and neurological status (KDIGO). 19

Conservative Management Is Not Appropriate When Multiple Absolute Indications Exist

• Conservative (non‑dialysis) management is reserved for truly asymptomatic patients or those who decline dialysis after informed consent (KDIGO). [19][20]
• When a patient exhibits four concurrent absolute indications—refractory volume overload with respiratory compromise, severe hyperkalemia, severe metabolic acidosis, and uremic symptoms—delaying dialysis is associated with preventable morbidity and likely mortality (KDIGO). 19